About the Melanocytic Lesions Session
Melanocytic lesions are pigmented skin abnormalities originating from melanocytes, the cells responsible for producing melanin. These lesions can vary widely in appearance, including nevi (moles), lentigines (sunspots), and more concerning forms such as melanoma. While most melanocytic lesions are benign, monitoring their changes in size, shape, or color is crucial, as these alterations can indicate malignant transformation.
In dermatology and cosmetology, the assessment of melanocytic lesions involves clinical examination and, when necessary, dermoscopy for enhanced visualization. Treatment options range from cosmetic removal for aesthetic concerns to surgical excision for suspected malignancies. Education on sun protection and regular skin checks is vital for prevention and early detection, ensuring optimal skin health and aesthetic outcomes.
Featured Speakers — Melanocytic Lesions 2027
Speaker lineup for this track will be announced soon.
Browse all speakers →Recent Research Presented at Melanocytic Lesions Sessions
Selected abstracts from this track will be published here.
Related Scientific Sessions at IDC 2027
Why Attend the Melanocytic Lesions Conference 2027
Present Your Research
Oral and poster slots for original Melanocytic Lesions work, reviewed by the scientific committee.
Network Globally
Meet researchers, clinicians, and industry leaders from around the world across three days.
Publish & Get Indexed
Accepted abstracts appear in the indexed conference proceedings with a citable DOI.
Learn from Keynotes
Plenary lectures from leading voices shaping Melanocytic Lesions research and practice.
Hybrid Flexibility
Attend in person in Rome or join virtually — same program, same certificate.
Join IDC 2027 for the Melanocytic Lesions track
Oral and poster slots for your work — in person in Rome or online. Not presenting? Attend as a delegate to learn from the field.
Melanocytic Lesions Conference 2027 — FAQs
What is the Melanocytic Lesions track at IDC 2027?
The Melanocytic Lesions track is a dedicated stream within IDC 2027 covering the latest research, clinical innovation, and best practice in Melanocytic Lesions. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Who should attend the Melanocytic Lesions sessions?
Researchers, clinicians, educators, doctoral students, and industry leaders with an interest in Melanocytic Lesions are all welcome — whether presenting or attending.
Can I present my research in the Melanocytic Lesions track?
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Is virtual attendance available for Melanocytic Lesions sessions?
Yes. IDC 2027 is a hybrid conference — attend the Melanocytic Lesions track in person in Rome or join live online, with on-demand access afterward.
Join the IDC 2027 delegation
Rome · June 21–23, 2027 · Hybrid · in-person & virtual
Attend without presenting.